NWPF

News ArchivesRead News

Your Parkinson's News Update for the Week of 8/17/20

Monday August 17, 2020
Switching off 'Master Regulator' May Shield the Brain from Parkinson's-Related Damage
Nature Neuroscience via MedicalXpress
Switching off a molecular "master regulator" may protect the brain from inflammatory damage and neurodegeneration in Parkinson's, reports a study published today in Nature Neuroscience.
"If we can find a way to protect critical brain cells from Parkinson's-related damage early on, we could potentially delay or even prevent symptom onset." said Viviane Labrie, Ph.D., an associate professor at Van Andel Institute and the study's senior author.
Caregivers Corner: Anxiety and Depression
Can be a Symptom of Parkinson’s
Capital Gazette
Many people do not realize that Parkinson’s is not just a movement disorder. Parkinson’s also affects the gastrointestinal system (causing constipation) and can cause hypotension (drop in blood pressure) which increases the risk of falling. And while we may assume that someone would feel anxious and depressed upon receiving a diagnosis of PD, many do not realize that anxiety and depression are clinical symptoms of the disease and not a reaction to it. Studies have shown that at least half of all Parkinson’s patients suffer from anxiety at some point during the course of the disease. This anxiety is associated with depression, dementia-like symptoms, and sleep disturbances. The good news is that anxiety can be treated with medications, lifestyle changes and therapy or counseling from a qualified practitioner.
New Perspectives in Early Diagnosis of Parkinson's
American Academy of Neruology via Medical Xpress
The American Academy of Neurology (AAN) has published the results of a research project conducted jointly by Cardiocentro Ticino and the EOC Neurocentro, which delivers a message of hope in the fight against Parkinson's disease. The study focuses on the analysis of blood plasma microvesicles (exosomes), which could allow the disease to be detected at a very early stage, favoring more effective therapeutic approaches. The new method, non-invasive and economical, requires a simple blood sample.